ENDOCRINE COMPLICATIONS OF THE NEW COVID-19 CORONAVIRUS INFECTION: THYROID AND ADRENAL GLANDS
Abstract
The objective of the study: to review the literature illustrating modern ideas about the potential role of the thyroid gland and adrenal glands in the infectious process of the COVID-19 new coronavirus infection.
Results: The new COVID-19 coronavirus infection is well known for its respiratory complications. However, as experience with COVID-19 patients has shown, it can also cause extrapulmonary manifestations, including cardiovascular, gastrointestinal, renal, hematological, hepatic, neurological, and endocrine disorders. Endocrine complications of COVID-19 are rare, and therefore less studied and require special attention. At the moment, COVID-19 is known to be a cause of the development of endocrine pathology on the part of the thyroid gland and adrenal glands, which is manifested by the following diseases: subacute thyroiditis, non-thyroidal illness syndrome, Hashimoto's thyroiditis, Graves’ disease, adrenal insufficiency and Cushing's syndrome. Studying the interaction between COVID-19 and the endocrine system in the future will make it possible to assess the severity of the disease and predict its outcome.
About the Authors
Ya. V. Malikova
ФГБОУ ВО «Башкирский государственный медицинский университет» Минздрава России
Russian Federation
Russian Federation
D. A. Valishin
ФГБОУ ВО «Башкирский государственный медицинский университет» Минздрава России
Russian Federation
Russian Federation
K. R. Enikeeva
ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова (Сеченовский Университет)» Минздрава России
Russian Federation
Russian Federation
References
1. Acute adrenal infarction as an incidental CT finding and a potential prognosis factor in severe SARS-CoV-2 infection: a retrospective cohort analysis on 219 patients / P. Leyendecker, S. Ritter, M. Riou [et al.] // Eur. Radiol. – 2021. – Vol. 31, № 2. – P. 895–900. doi:10.1007/s00330-020-07226-5.
2. Association between high serum total cortisol concentrations and mortality from COVID-19 / T. Tan, B. Khoo, E.G. Mills [et al.] // Lancet Diabetes Endocrinol. – 2020. – Vol. 8, № 8. – P. 659-660. doi: 10.1016/S2213-8587(20)30216-3.
3. Case report: adrenal pathology findings in severe COVID-19: an autopsy study / M. Freire Santana, M.G.S. Borba, D.C. Baía-da-Silva [et al.] // Am. J. Trop. Med. Hygiene. – 2020. – Vol. 103, № 4. – P. 1604–1607. doi: 10.4269/ajtmh.20-0787.
4. Case report: COVID-19 with bilateral adrenal hemorrhage / J. Álvarez-Troncoso, M. Zapatero Larrauri, M.D. Montero Vega [et al.] // Am. J. Trop. Med. Hygiene. – 2020. – Vol. 103, № 3. – P. 1156-1157. doi: 10.4269/ajtmh.20-0722.
5. Clinical characteristics of subacute thyroiditis is different than it used to be – current state based on 15 years own material / M. Stasiak, R. Michalak, B. Stasiak, A. Lewinski // Neuro Endocrinol. Lett. – 2018. – Vol. 39, № 7. – P. 101–107.
6. Clinical course and outcome of patients with ACTH-dependent Cushing’s syndrome infected with novel coronavirus disease-19 (COVID-19): case presentations / Z. Belaya, O. Golounina, G. Melnichenko [et al.] // Endocrine. – 2021. – Vol. 72, № 1. – P. 12-19. doi: 10.1007/s12020-021-02674-5.
7. COVID-19 and Cushing’s syndrome: recommendations for a special population with endogenous glucocorticoid excess / R. Pivonello, R. Ferrigno, A. M. Isidori [et al.] // Lancet Diabetes Endocrinol. – 2020. – № 8, № 8. – P. 654–656. doi: 10.1016/S2213-8587(20)30215-1.
8. COVID-19 and the endocrine system: a comprehensive review on the theme / G. Lisco, A. De Tullio, A. Stragapede [et al.] // J. Clin. Med. – 2021. – Vol. 10, № 13. – P. 2920. doi: 10.3390/jcm10132920.
9. COVID-19 Dashboard / Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). – Режим доступа: https://coronavirus.jhu.edu/map.html (Дата обращения: 20.01.2023).
10. COVID‐19: virology, biology and novel laboratory diagnosis / M. Mohamadian, H. Chiti, A. Shoghli, [et al.] // J. Gene Med. – 2021. – Vol. 23, № 2. – P. e3303. doi: 10.1002/jgm.3303.
11. Desailloud, R. Viruses and thyroiditis: an update / R. Desailloud, D. Hober // Virol. J. – 2009. – № 6. – P. 1–14. doi: 10.1186/1743-422X-6-5.
12. Detection of SARSCOV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis / M. Rotondi, F. Coperchini, G. Ricci [et al.] // J. Endocrinol. Investig. – 2021. – Vol. 44, № 5. – P. 1085–1090. doi: 10.1007/s40618-020-01436-w.
13. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues / M.Y. Li, L. Li, Y. Zhang, X.S. Wang // Infect. Dis. Poverty. – 2020. – Vol. 9, № 1. – P. 45. doi: 10.1186/s40249-020-00662-x.
14. Graves’ disease after COVID-19 / T.A. Moreno, G.L. Paloma, P.C. Contreras [et al.] // Endocrine Abstr. – 2021. – Vol. 73. – P. AEP760.
15. Harris, A. Graves’ thyrotoxicosis following SARSCoV-2 infection / A. Harris, M. Al Mushref // AACE Clin. Case Rep. – 2021. – № 7. – P. 14–16.
16. Immunebased therapy for COVID-19 / A. Esmaeilzadeh, D. Jafari, S. Tahmasebi [et al.] // Adv. Exp. Med. Biol. – 2021. – № 1318. – P. 449–468. doi: 10.1007/978-3-030-63761-3_26.
17. Inflammatory cell infiltration of adrenals in COVID-19 / V.A. Zinserling, N.Y. Semenova, A.G. Markov [et al.] // Hormone Metab. Res. – 2020. – Vol. 52, № 9. – P. 639–641. doi: 10.1055/a-1191-8094.
18. Lazartigues, E. Endocrine significance of SARS-CoV-2’s reliance on ACE2 / E. Lazartigues, M.M.F. Qadir, F. Mauvais-Jarvis // Endocrinology. – 2020. – Vol. 161, № 9. – P. bqaa108. doi: 10.1210/endocr/bqaa108.
19. Multi-organ involvement in COVID-19: beyond pulmonary manifestations / V. Thakur, R.K. Ratho, P. Kumar [et al.] // J. Clin. Med. - 2021. – Vol. 10, № 3. – P. 446. doi: 10.3390/jcm10030446.
20. Pal, R. COVID-19, hypothalamo-pituitary-adrenal axis and clinical implications / R. Pal // Endocrine. – 2020. – Vol. 68, № 2. – P. 251–252. doi: 10.1007/s12020-020-02325-1.
21. Palpitations and fatigue post COVID: a harbinger of silent thyroiditis / M.A.G. Chan, B.T. Teweldemedhin, J.M. Demigillo [et al.] // J. Endocrine Soc. – 2021. – № 5. – P. A946–A946.
22. Prognostic significance of low TSH concentration in patients with COVID-19 presenting with non-thyroidal illness syndrome / J. Gong, D.K. Wang, H. Dong [et al.] // BMC Endocrine Disord. – 2021. – Vol. 21, № 1. – P. 111. doi: 10.1186/s12902-021-00766-x.
23. Rapid and sensitive diagnostic procedure for multiple detection of pandemic Coronaviridae family members SARS-CoV-2, SARS-CoV, MERS-CoV and HCoV: a translational research and cooperation between the Phan Chau Trinh University in Vietnam and University of Bari ‘Aldo Moro’ in Italy / V.H. Pham, C.G. Isacco, K.C.D. Nguyen [et al.] // Eur. Rev. Med. Pharmacol. Sci. – 2020. – Vol. 24, № 12. – P. 7173–7191. doi: 10.26355/eurrev_202006_21713.
24. Risk factors for adverse outcomes of COVID-19 patients: possible basis for diverse responses to the novel coronavirus SARS-CoV-2 / M. Ghaebi, S. Tahmasebi, M. Jozghorbani [et al.] // Life Sci. – 2021. – Vol. 277. – P. 119503. doi: 10.1016/j.lfs.2021.119503.
25. Role of non‐thyroidal illness syndrome in predicting adverse outcomes in COVID‐19 patients predominantly of mild‐to‐moderate severity / D.T.W. Lui, C.H. Lee, W.S. Chow [et al.] // Clin. Endocrinol. (Oxf). – 2021. – Vol. 95, № 3. – P. 469-477. doi: 10.1111/cen.14476.
26. Samuels, M.H. Subacute, silent, and postpartum thyroiditis / M.H. Samuels // Med. Clin. North Am. – 2012. – Vol. 96, № 2. – P. 223–233. doi: 10.1111/cen.14476.
27. SARS-CoV-2-related atypical thyroiditis / I. Muller, D. Cannavaro, D. Dazzi [et al.] // Lancet: Diabet. Endocrinol. – 2020. – Vol. 8, № 9. – P. 739–741. doi: 10.1016/S2213-8587(20)30266-7.
28. Sorci, G. Explaining among-country variation in COVID-19 case fatality rate / G. Sorci, B. Faivre, S. Morand // Sci. Rep. – 2020. – Vol. 10, № 1. –P. 18909.
29. Tee, L.Y. COVID-19 complicated by Hashimoto’s thyroiditis / L.Y. Tee, S. Hajanto, B.H. Rosario // Singapore Med. J. – 2020. – Vol. 62, № 5. – P. 265. doi: 10.11622/smedj.2020106.
30. Thyroid function before, during, and after COVID-19 / B. Khoo, T. Tan, S.A. Clarke [et al.] // J. Clin. Endocrinol. Metab. – 2021. – Vol. 106, № 2. – P. e803–e811. doi: 10.1210/clinem/dgaa830.
31. Warner, M.H. Mechanisms behind the non-thyroidal illness syndrome: an update / M.H. Warner, G.J. Beckett // J. Endocrinol. – 2010. – Vol. 205, № 1. – P. 1–13. doi: 10.1677/JOE-09-0412.
Review
For citations:
Malikova Ya.V., Valishin D.A., Enikeeva K.R. ENDOCRINE COMPLICATIONS OF THE NEW COVID-19 CORONAVIRUS INFECTION: THYROID AND ADRENAL GLANDS. Bashkortostan Medical Journal. 2023;18(3):83-88. (In Russ.)
Views:
37
Email this article 
